Free Trial

Alector (ALEC) Financials

Alector logo
$1.87 -0.21 (-10.10%)
Closing price 10/13/2026 04:00 PM Eastern
Extended Trading
$1.90 +0.03 (+1.76%)
As of 07:50 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Alector

Annual Income Statements for Alector

This table shows Alector's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-32 -52 -241 -190 -36 -133 -130 -119 -143
Consolidated Net Income / (Loss)
-32 -52 -105 -190 -36 -133 -130 -119 -143
Net Income / (Loss) Continuing Operations
-32 -52 -241 -190 -36 -133 -130 -119 -143
Total Pre-Tax Income
-32 -52 -241 -190 -36 -130 -125 -119 -143
Total Operating Income
-33 -57 -114 -195 -37 -138 -152 -145 -156
Total Gross Profit
3.74 28 21 21 207 134 97 101 21
Total Revenue
3.74 28 0.00 21 207 134 97 101 21
Operating Revenue
3.74 28 21 21 207 134 97 101 21
Total Cost of Revenue
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses
36 85 271 216 244 271 249 246 177
Selling, General & Admin Expense
6.50 12 35 59 55 61 57 60 54
Research & Development Expense
30 73 101 157 189 210 192 186 123
Total Other Income / (Expense), net
0.20 5.04 9.02 4.95 1.03 7.78 27 26 13
Other Income / (Expense), net
0.20 5.04 9.02 4.95 1.03 7.78 27 26 13
Income Tax Expense
- - - 0.00 0.00 3.25 5.21 0.13 0.17
Basic Earnings per Share
($3.55) ($4.62) ($1.71) ($2.45) ($0.45) ($1.62) ($1.56) ($1.23) ($1.39)
Weighted Average Basic Shares Outstanding
9.14M 11.30M 61.73M 77.76M 80.42M 82.47M 83.73M 96.59M 103.00M
Diluted Earnings per Share
($3.55) ($4.62) ($1.71) ($2.45) ($0.45) ($1.62) ($1.56) ($1.23) ($1.39)
Weighted Average Diluted Shares Outstanding
9.14M 11.30M 61.73M 77.76M 80.42M 82.47M 83.73M 96.59M 103.00M
Weighted Average Basic & Diluted Shares Outstanding
9.14M 11.30M 61.73M 77.76M 80.42M 83.03M 95.75M 99.09M 110.36M

Quarterly Income Statements for Alector

This table shows Alector's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-41 -36 -39 -42 -2.07 -40 -31 -35 -37 -23 -23
Consolidated Net Income / (Loss)
-41 -36 -39 -42 -2.07 -40 -31 -35 -37 -23 -23
Net Income / (Loss) Continuing Operations
-41 -36 -39 -42 -2.07 -40 -31 -35 -37 -23 -23
Total Pre-Tax Income
-40 -36 -39 -42 -2.03 -40 -31 -35 -37 -23 -23
Total Operating Income
-47 -44 -46 -48 -7.25 -45 -34 -38 -40 -25 -24
Total Gross Profit
15 16 15 15 54 3.67 7.87 3.26 6.24 1.05 3.32
Total Revenue
15 16 15 15 54 3.67 7.87 3.26 6.24 1.05 3.32
Operating Revenue
15 16 15 15 54 3.67 7.87 3.26 6.24 1.05 3.32
Total Cost of Revenue
- 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Operating Expenses
63 60 61 64 61 48 42 41 46 26 28
Selling, General & Admin Expense
15 14 14 16 15 15 14 12 13 8.11 8.25
Research & Development Expense
48 45 46 48 46 34 28 29 32 18 19
Total Other Income / (Expense), net
7.69 7.64 7.00 6.21 5.22 4.22 3.61 2.94 2.47 1.99 1.53
Other Income / (Expense), net
7.69 7.64 7.00 6.21 5.22 4.22 3.61 2.94 2.47 1.99 1.53
Income Tax Expense
1.67 0.01 0.07 0.00 0.05 0.00 0.00 0.00 0.17 0.00 0.13
Basic Earnings per Share
($0.50) ($0.38) ($0.40) ($0.43) ($0.02) ($0.41) ($0.30) ($0.34) ($0.34) ($0.21) ($0.21)
Weighted Average Basic Shares Outstanding
83.73M 93.81M 96.67M 97.52M 96.59M 99.40M 100.37M 102.60M 103.00M 110.59M 111.22M
Diluted Earnings per Share
($0.50) ($0.38) ($0.40) ($0.43) ($0.02) ($0.41) ($0.30) ($0.34) ($0.34) ($0.21) ($0.21)
Weighted Average Diluted Shares Outstanding
83.73M 93.81M 96.67M 97.52M 96.59M 99.40M 100.37M 102.60M 103.00M 110.59M 111.22M
Weighted Average Basic & Diluted Shares Outstanding
95.75M 96.38M 97.32M 97.93M 99.09M 99.99M 101.21M 109.15M 110.36M 111.03M 111.66M

Annual Cash Flow Statements for Alector

This table details how cash moves in and out of Alector's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-19 34 24 -40 279 -175 -80 -41 33
Net Cash From Operating Activities
-18 127 -99 -167 299 -20 -184 -230 -184
Net Cash From Continuing Operating Activities
-18 127 -99 -167 299 -20 -184 -230 -184
Net Income / (Loss) Continuing Operations
-32 -52 -105 -190 -36 -133 -130 -119 -143
Consolidated Net Income / (Loss)
-32 -52 -105 -190 -36 -133 -130 -119 -143
Depreciation Expense
0.68 1.02 3.78 5.87 6.33 5.71 5.73 5.41 5.72
Amortization Expense
0.00 -2.75 -2.90 1.98 4.09 1.60 -12 -11 -2.34
Non-Cash Adjustments To Reconcile Net Income
5.35 7.08 18 31 33 51 53 40 41
Changes in Operating Assets and Liabilities, net
8.68 174 -13 -15 291 55 -100 -145 -85
Net Cash From Investing Activities
-0.80 -224 -49 -105 -50 -159 102 107 197
Net Cash From Continuing Investing Activities
-0.80 -224 -49 -105 -50 -159 102 107 197
Purchase of Property, Plant & Equipment
-0.80 -1.88 -15 -5.03 -3.25 -4.12 -2.38 -1.26 -0.04
Purchase of Investments
0.00 -472 -530 -507 -343 -557 -552 -468 -272
Sale and/or Maturity of Investments
0.00 250 496 407 297 402 656 576 469
Net Cash From Financing Activities
-0.02 131 172 232 30 4.51 2.55 82 20
Net Cash From Continuing Financing Activities
-0.02 131 172 232 30 4.51 2.55 82 20
Repayment of Debt
- -1.90 - - - 0.00 0.00 9.39 0.00
Issuance of Common Equity
0.00 0.00 0.80 1.18 1.77 1.46 1.47 72 20
Other Financing Activities, net
0.00 0.00 1.52 6.33 29 3.06 1.08 0.00 0.02
Cash Interest Paid
- - - - - - - 0.00 0.86

Quarterly Cash Flow Statements for Alector

This table details how cash moves in and out of Alector's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
-27 -2.00 -25 -10 -3.84 4.95 6.80 32 -11 11 -17
Net Cash From Operating Activities
-46 -61 -63 -51 -55 -61 -49 -33 -42 -50 -34
Net Cash From Continuing Operating Activities
-46 -61 -63 -51 -55 -61 -49 -33 -42 -50 -34
Net Income / (Loss) Continuing Operations
-41 -36 -39 -42 -2.07 -40 -31 -35 -37 -23 -23
Consolidated Net Income / (Loss)
-41 -36 -39 -42 -2.07 -40 -31 -35 -37 -23 -23
Depreciation Expense
1.44 1.44 1.40 1.32 1.24 0.98 2.33 1.24 1.17 1.08 1.05
Amortization Expense
-3.99 -3.73 -3.08 -2.39 -1.74 -1.09 -0.79 -0.38 -0.08 0.41 0.58
Non-Cash Adjustments To Reconcile Net Income
30 18 0.09 12 9.35 11 5.78 11 13 -4.15 -3.90
Changes in Operating Assets and Liabilities, net
-32 -41 -23 -20 -62 -32 -26 -9.29 -19 -24 -8.95
Net Cash From Investing Activities
18 -12 37 40 41 66 56 50 26 61 17
Net Cash From Continuing Investing Activities
18 -12 37 40 41 66 56 50 26 61 17
Purchase of Property, Plant & Equipment
-0.23 -0.53 -0.34 -0.21 -0.17 -0.02 -0.01 -0.01 - -0.12 -0.03
Purchase of Investments
-137 -196 -101 -83 -87 -56 -76 -59 -81 -52 -28
Sale and/or Maturity of Investments
156 185 139 124 128 122 132 109 107 113 45
Net Cash From Financing Activities
0.59 71 0.64 - 9.79 0.00 0.12 15 5.39 0.03 0.05
Net Cash From Continuing Financing Activities
0.59 71 0.64 - 9.79 0.00 0.12 15 5.39 0.03 0.05
Other Financing Activities, net
- 0.00 - - - 0.00 - - - 0.03 0.00
Cash Interest Paid
- 0.00 - - - 0.21 0.00 0.00 0.64 0.20 0.20

Annual Balance Sheets for Alector

This table presents Alector's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
308 422 488 815 788 622 468 293
Total Current Assets
293 357 422 750 726 566 425 266
Cash & Equivalents
65 90 50 329 154 75 33 66
Short-Term Investments
225 263 363 406 559 474 380 190
Prepaid Expenses
2.77 4.36 8.20 7.07 11 17 11 10
Plant, Property, & Equipment, net
11 34 30 27 26 22 17 11
Total Noncurrent Assets
4.25 31 37 38 36 34 26 16
Other Noncurrent Operating Assets
4.25 31 37 38 36 34 26 16
Total Liabilities & Shareholders' Equity
308 422 488 815 788 622 468 293
Total Liabilities
195 227 221 514 573 488 342 263
Total Current Liabilities
48 62 68 140 94 178 125 70
Short-Term Debt
- - - - - - 0.00 0.37
Accounts Payable
0.13 0.28 3.00 4.75 4.19 3.78 2.22 1.69
Accrued Expenses
13 25 34 36 33 36 36 23
Current Deferred Revenue
35 30 24 91 48 83 24 6.68
Other Current Liabilities
0.00 6.57 7.51 7.80 8.06 56 63 38
Total Noncurrent Liabilities
147 165 153 374 479 310 216 193
Long-Term Debt
- - - - - 0.00 9.39 9.32
Noncurrent Deferred Revenue
147 123 108 334 443 211 172 165
Other Noncurrent Operating Liabilities
0.10 42 44 40 36 99 35 19
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-97 195 268 301 214 134 127 31
Total Preferred & Common Equity
-97 195 268 301 214 134 127 31
Total Common Equity
-97 195 268 301 214 134 127 31
Common Stock
17 414 677 748 799 844 956 1,003
Retained Earnings
-114 -220 -410 -446 -580 -710 -829 -972
Accumulated Other Comprehensive Income / (Loss)
-0.04 0.14 0.61 -0.94 -4.58 0.18 0.26 0.17

Quarterly Balance Sheets for Alector

This table presents Alector's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
672 635 571 516 408 356 335 240 203
Total Current Assets
613 581 520 469 367 319 300 215 180
Cash & Equivalents
102 73 48 37 38 45 77 77 60
Short-Term Investments
487 490 456 420 317 263 215 130 113
Prepaid Expenses
14 19 16 12 12 12 9.28 8.57 7.29
Plant, Property, & Equipment, net
23 21 20 18 16 14 13 9.93 8.91
Total Noncurrent Assets
36 33 31 28 25 23 22 15 14
Other Noncurrent Operating Assets
36 33 31 28 25 23 22 15 14
Total Liabilities & Shareholders' Equity
672 635 571 516 408 356 335 240 203
Total Liabilities
510 457 420 397 314 285 278 230 213
Total Current Liabilities
155 165 148 143 110 84 80 41 34
Short-Term Debt
- - - - - - - 1.48 9.85
Accounts Payable
4.68 4.59 4.38 5.02 2.33 2.22 4.76 1.42 2.28
Accrued Expenses
38 25 26 29 23 19 22 12 9.18
Current Deferred Revenue
81 73 64 55 22 13 12 6.72 0.00
Other Current Liabilities
32 62 54 53 62 49 42 19 13
Total Noncurrent Liabilities
354 292 272 255 204 201 198 189 179
Long-Term Debt
- - - - 9.46 9.54 9.61 8.29 0.00
Noncurrent Deferred Revenue
230 205 200 193 170 169 167 163 163
Other Noncurrent Operating Liabilities
125 87 73 62 24 22 21 17 16
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
163 179 151 119 95 71 58 10 -9.97
Total Preferred & Common Equity
163 179 151 119 95 71 58 10 -9.97
Total Common Equity
163 179 151 119 95 71 58 10 -9.97
Common Stock
832 925 936 945 964 971 992 1,005 1,008
Retained Earnings
-669 -746 -785 -827 -870 -900 -935 -995 -1,018
Accumulated Other Comprehensive Income / (Loss)
-0.72 -0.40 -0.62 0.93 0.19 0.10 0.20 -0.10 -0.13

Annual Metrics And Ratios for Alector

This table displays calculated financial ratios and metrics derived from Alector's official financial filings.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 0.00 68,923,730.00 79,242,709.00 81,276,097.00 82,701,539.00 84,136,381.00 - 109,151,472.00
DEI Adjusted Shares Outstanding
0.00 0.00 68,923,730.00 79,242,709.00 81,276,097.00 82,701,539.00 84,136,381.00 - 109,151,472.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 -3.50 -2.40 -0.45 -1.61 -1.55 - -1.31
Growth Metrics
- - - - - - - - -
Revenue Growth
0.00% 641.02% -100.00% 0.00% 881.54% -35.48% -27.36% 3.60% -79.07%
EBITDA Growth
0.00% -69.73% -187.27% -74.51% 85.79% -373.65% -7.25% 5.46% -11.99%
EBIT Growth
0.00% -60.86% -101.70% -80.51% 80.90% -258.00% 3.75% 5.00% -20.05%
NOPAT Growth
0.00% -75.31% -99.70% -70.60% 80.86% -268.93% -10.09% 4.44% -7.59%
Net Income Growth
0.00% -60.86% -203.40% -80.51% 80.90% -266.95% 2.19% 8.70% -20.06%
EPS Growth
0.00% -30.14% 125.97% -43.27% 81.63% -260.00% 3.70% 21.15% -13.01%
Operating Cash Flow Growth
0.00% 817.26% -355.82% -67.90% 279.06% -106.81% -805.91% -24.84% 19.95%
Free Cash Flow Firm Growth
0.00% 0.00% -172.19% -50.62% 276.03% -112.42% -482.56% -25.84% 28.56%
Invested Capital Growth
0.00% 0.00% 10.69% 7.93% -198.07% -14.70% 16.79% 33.16% 22.19%
Revenue Q/Q Growth
0.00% 0.00% -200.00% 362.18% 0.03% 0.33% 0.78% 63.49% -69.52%
EBITDA Q/Q Growth
0.00% 0.00% 48.71% -8.27% -0.92% 0.27% 6.20% 24.23% -31.61%
EBIT Q/Q Growth
0.00% 0.00% -8.52% -8.85% -5.64% 2.91% 8.71% 24.09% -32.57%
NOPAT Q/Q Growth
0.00% 0.00% -13.18% -11.68% -8.64% 0.21% 5.00% 21.71% -26.13%
Net Income Q/Q Growth
0.00% 0.00% -28.52% -12.84% -10.42% 2.33% 7.78% 24.85% -32.67%
EPS Q/Q Growth
0.00% 0.00% 75.64% -9.38% 15.09% -3.18% 8.24% 28.07% -29.91%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -12.68% -12.73% -0.54% 1.65% 1.53% -4.05% 6.76%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 49.69% -1.41% 2.52% 0.41% -9.79% 15.09%
Invested Capital Q/Q Growth
0.00% 0.00% 102.78% 3.79% 1.68% 1.34% 2.72% 18.05% 3.62%
Profitability Metrics
- - - - - - - - -
Gross Margin
100.00% 100.00% 0.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin
-851.41% -195.01% 0.00% -864.44% -12.51% -91.86% -135.63% -123.77% -662.32%
Operating Margin
-874.94% -206.99% 0.00% -925.08% -18.04% -103.16% -156.33% -144.19% -741.30%
EBIT Margin
-869.61% -188.78% 0.00% -901.64% -17.54% -97.33% -128.97% -118.26% -678.36%
Profit (Net Income) Margin
-869.61% -188.78% 0.00% -901.64% -17.54% -99.77% -134.34% -118.39% -679.16%
Tax Burden Percent
100.00% 100.00% 87.45% 100.00% 100.00% 102.50% 104.16% 100.11% 100.12%
Interest Burden Percent
100.00% 100.00% 457.39% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% -46.19% -68.46% -82.30% -12.79% -51.75% -74.81% -91.24% -181.56%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% -16.94% 0.00% -41.80% -5.58% -16.23% -17.76% -21.82% -37.49%
Return on Assets (ROA)
0.00% -16.94% 0.00% -41.80% -5.58% -16.64% -18.50% -21.84% -37.54%
Return on Common Equity (ROCE)
0.00% 39.77% -43.29% -82.30% -12.79% -51.75% -74.81% -91.24% -181.56%
Return on Equity Simple (ROE_SIMPLE)
0.00% 53.64% -108.23% -71.11% -12.08% -62.17% -97.19% -93.89% 0.00%
Net Operating Profit after Tax (NOPAT)
-23 -40 -80 -137 -26 -96 -106 -101 -109
NOPAT Margin
-612.46% -144.89% 0.00% -647.56% -12.63% -72.21% -109.43% -100.93% -518.91%
Net Nonoperating Expense Percent (NNEP)
0.00% -8.37% -15.03% -13.99% -1.77% -5.09% -3.83% -3.68% -10.37%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - -44.99% -79.17% -74.53% -270.72%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
174.11% 43.12% 0.00% 281.56% 26.58% 45.68% 58.40% 59.28% 256.53%
R&D to Revenue
800.83% 263.87% 0.00% 743.53% 91.46% 157.48% 197.93% 184.91% 584.77%
Operating Expenses to Revenue
974.94% 306.99% 0.00% 1,025.08% 118.04% 203.16% 256.33% 244.19% 841.30%
Earnings before Interest and Taxes (EBIT)
-32 -52 -105 -190 -36 -130 -125 -119 -143
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-32 -54 -105 -182 -26 -123 -132 -124 -139
Valuation Ratios
- - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 11.56 4.48 5.58 3.56 5.00 1.46 5.56
Price to Tangible Book Value (P/TBV)
0.00 0.00 11.56 4.48 5.58 3.56 5.00 1.46 5.56
Price to Revenue (P/Rev)
47.05 6.35 0.00 56.83 8.10 5.71 6.92 1.84 8.09
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 3.46 0.00 37.24 4.55 0.38 1.26 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.75 0.00 0.00 3.16 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.70 0.00 0.00 3.59 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.32
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.30
Financial Leverage
0.00 -2.57 -2.09 -1.66 -2.02 -2.81 -3.62 -3.65 -4.13
Leverage Ratio
0.00 2.73 4.74 1.97 2.29 3.11 4.04 4.18 4.84
Compound Leverage Factor
0.00 2.73 5.42 1.97 2.29 3.11 4.04 4.18 4.84
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.89% 24.02%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.91%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.89% 23.11%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 186.10% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% -86.10% 200.00% 100.00% 100.00% 100.00% 100.00% 93.11% 75.98%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.08 -0.07
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.25 1.77
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.08 -0.07
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.09 -0.09
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.98 2.26
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.09 -0.09
Altman Z-Score
0.00 0.51 2.42 1.71 2.20 0.36 -0.53 -2.01 -4.98
Noncontrolling Interest Sharing Ratio
0.00% 186.10% 68.38% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - -
Current Ratio
0.00 6.11 5.77 6.19 5.37 7.74 3.18 3.40 3.83
Quick Ratio
0.00 6.06 11.40 6.07 5.27 7.60 3.08 3.31 3.68
Cash Flow Metrics
- - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 137 -99 -149 263 -33 -190 -239 -171
Operating Cash Flow to CapEx
-2,218.60% 6,765.61% -1,301.12% -3,313.47% 9,194.67% -493.78% -7,734.65% -18,319.12% -448,856.10%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - -
Asset Turnover
0.00 0.09 0.00 0.05 0.32 0.17 0.14 0.18 0.06
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 2.53 0.00 0.66 7.20 5.06 4.10 5.16 1.50
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - -
Invested Capital
0.00 -177 -158 -146 -435 -498 -415 -277 -216
Invested Capital Turnover
0.00 -0.31 0.00 -0.14 -0.71 -0.29 -0.21 -0.29 -0.09
Increase / (Decrease) in Invested Capital
0.00 -177 19 13 -289 -64 84 137 62
Enterprise Value (EV)
0.00 96 1,545 786 943 50 123 -219 -76
Market Capitalization
176 176 1,188 1,199 1,678 763 671 185 170
Book Value per Share
$0.00 ($8.62) $2.83 $3.38 $3.70 $2.59 $1.59 $1.29 $0.28
Tangible Book Value per Share
$0.00 ($8.62) $2.83 $3.38 $3.70 $2.59 $1.59 $1.29 $0.28
Total Capital
0.00 113 195 268 301 214 134 136 40
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.39 9.69
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.39 9.32
Net Debt
0.00 -290 -353 -413 -735 -713 -549 -404 -246
Capital Expenditures (CapEx)
0.80 1.88 15 5.03 3.25 4.12 2.38 1.26 0.04
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -45 -58 -60 -125 -80 -161 -114 -59
Debt-free Net Working Capital (DFNWC)
0.00 245 295 353 610 633 388 300 197
Net Working Capital (NWC)
0.00 245 295 353 610 633 388 300 197
Net Nonoperating Expense (NNE)
9.60 12 25 54 10 37 24 18 34
Net Nonoperating Obligations (NNO)
0.00 -290 -353 -413 -735 -713 -549 -404 -246
Total Depreciation and Amortization (D&A)
0.68 -1.73 0.87 7.85 10 7.31 -6.47 -5.54 3.38
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -163.24% 0.00% -283.84% -60.41% -60.04% -165.88% -113.01% -278.97%
Debt-free Net Working Capital to Revenue
0.00% 886.04% 0.00% 1,675.15% 294.64% 473.46% 399.60% 298.09% 937.59%
Net Working Capital to Revenue
0.00% 886.04% 0.00% 1,675.15% 294.64% 473.46% 399.60% 298.09% 935.85%
Earnings Adjustments
- - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($1.71) ($2.45) ($0.45) ($1.62) ($1.56) ($1.23) ($1.39)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 78.98M 79.58M 82.04M 82.47M 83.73M 96.59M 103.00M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($1.71) ($2.45) ($0.45) ($1.62) ($1.56) ($1.23) ($1.39)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 78.98M 79.58M 82.04M 82.47M 83.73M 96.59M 103.00M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 ($1.71) ($2.45) ($0.45) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 61.73M 77.76M 80.42M 83.03M 95.75M 99.09M 110.36M
Normalized Net Operating Profit after Tax (NOPAT)
-23 -40 -80 -137 -26 -96 -106 -101 -109
Normalized NOPAT Margin
-612.46% -144.89% 0.00% -647.56% -12.63% -72.21% -109.43% -100.93% -518.91%
Pre Tax Income Margin
-869.61% -188.78% 0.00% -901.64% -17.54% -97.33% -128.97% -118.26% -678.36%
Debt Service Ratios
- - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Alector

This table displays calculated financial ratios and metrics derived from Alector's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
84,136,381.00 84,136,381.00 96,384,562.00 97,321,062.00 - 99,085,888.00 99,992,600.00 101,212,329.00 109,151,472.00 110,362,581.00 111,025,187.00
DEI Adjusted Shares Outstanding
84,136,381.00 84,136,381.00 96,384,562.00 97,321,062.00 - 99,085,888.00 99,992,600.00 101,212,329.00 109,151,472.00 110,362,581.00 111,025,187.00
DEI Earnings Per Adjusted Shares Outstanding
-0.49 -0.43 -0.40 -0.43 - -0.41 -0.31 -0.34 -0.34 -0.21 -0.21
Growth Metrics
- - - - - - - - - - -
Revenue Growth
5.19% -3.96% -73.17% 68.43% 257.08% -76.88% -47.80% -78.75% -88.50% -71.53% -57.84%
EBITDA Growth
17.07% 15.60% -2,503.34% 4.97% 94.03% -5.79% 28.03% 21.91% -1,324.93% 47.18% 26.76%
EBIT Growth
23.09% 19.76% -1,494.62% 2.32% 94.91% -12.20% 20.93% 17.89% -1,731.15% 43.34% 25.11%
NOPAT Growth
14.40% 12.78% -1,690.65% 4.25% 84.72% -2.26% 25.15% 22.35% -445.81% 44.25% 28.55%
Net Income Growth
20.97% 21.32% -2,912.80% 5.07% 94.99% -12.17% 21.08% 17.89% -1,696.87% 43.34% 24.68%
EPS Growth
21.88% 30.91% -2,100.00% 18.87% 96.00% -7.89% 25.00% 20.93% -1,600.00% 48.78% 30.00%
Operating Cash Flow Growth
5.84% -26.36% -46.03% -9.01% -19.44% 0.92% 21.90% 35.92% 24.24% 18.05% 30.23%
Free Cash Flow Firm Growth
-566.29% 10.73% -27.74% -6.68% -21.93% -22.62% -32.95% -15.47% 37.42% 50.27% 52.88%
Invested Capital Growth
16.79% 21.21% 18.67% 20.65% 33.16% 34.63% 35.77% 33.84% 22.19% 25.60% 23.68%
Revenue Q/Q Growth
66.76% 4.63% -5.10% 1.72% 253.54% -93.23% 114.32% -58.60% 91.32% -83.23% 217.40%
EBITDA Q/Q Growth
7.11% 9.35% -5.01% -7.48% 94.16% -1,505.90% 28.57% -16.62% -6.51% 40.47% 0.94%
EBIT Q/Q Growth
7.99% 9.29% -7.02% -9.37% 95.20% -1,897.58% 24.58% -13.57% -7.02% 38.19% 0.31%
NOPAT Q/Q Growth
6.19% 7.89% -4.34% -6.20% 85.03% -516.57% 23.62% -10.16% -5.21% 37.02% 2.11%
Net Income Q/Q Growth
6.84% 12.92% -7.20% -9.16% 95.09% -1,851.35% 24.58% -13.57% -7.50% 38.47% -0.26%
EPS Q/Q Growth
5.66% 24.00% -5.26% -7.50% 95.35% -1,950.00% 26.83% -13.33% 0.00% 38.24% 0.00%
Operating Cash Flow Q/Q Growth
1.01% -33.16% -2.37% 19.21% -8.46% -10.46% 19.31% 33.71% -28.24% -19.48% 31.31%
Free Cash Flow Firm Q/Q Growth
-2.29% -14.38% 15.58% -8.01% -16.92% -15.02% 8.47% 6.19% 36.64% 8.59% 13.28%
Invested Capital Q/Q Growth
2.72% 7.60% 7.94% 4.11% 18.05% 9.64% 9.55% 1.23% 3.62% 13.59% 7.21%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin
-278.59% -241.36% -267.06% -282.18% -4.66% -1,104.55% -368.16% -1,037.06% -577.33% -2,049.24% -639.55%
Operating Margin
-312.40% -275.01% -302.37% -315.70% -13.36% -1,216.52% -433.55% -1,153.62% -634.38% -2,382.31% -734.73%
EBIT Margin
-261.80% -226.97% -255.94% -275.19% -3.74% -1,101.55% -387.66% -1,063.40% -594.82% -2,192.16% -688.55%
Profit (Net Income) Margin
-272.77% -227.01% -256.42% -275.19% -3.82% -1,101.55% -387.66% -1,063.40% -597.51% -2,192.16% -692.47%
Tax Burden Percent
104.19% 100.02% 100.19% 100.00% 102.37% 100.00% 100.00% 100.00% 100.45% 100.00% 100.57%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-74.81% -66.65% -92.64% -112.55% -91.24% -90.26% -103.98% -121.98% -181.56% -238.85% -385.11%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
-36.06% -31.62% -22.11% -28.49% -0.69% -186.45% -67.84% -172.50% -32.88% -124.57% -34.13%
Return on Assets (ROA)
-37.57% -31.63% -22.16% -28.49% -0.71% -186.45% -67.84% -172.50% -33.02% -124.57% -34.33%
Return on Common Equity (ROCE)
-74.81% -66.65% -92.64% -112.55% -91.24% -90.26% -103.98% -121.98% -181.56% -238.85% -385.11%
Return on Equity Simple (ROE_SIMPLE)
0.00% -67.42% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-33 -31 -32 -34 -5.07 -31 -24 -26 -28 -17 -17
NOPAT Margin
-218.68% -192.51% -211.66% -220.99% -9.36% -851.57% -303.49% -807.53% -444.06% -1,667.62% -514.31%
Net Nonoperating Expense Percent (NNEP)
-1.30% -0.89% -1.19% -1.59% 0.63% -2.02% -1.65% -2.26% -2.94% -2.03% -2.57%
Return On Investment Capital (ROIC_SIMPLE)
-24.76% -17.10% -21.20% -28.51% -3.73% -30.06% -29.61% -39.10% -68.66% -86.57% 13,995.98%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
98.22% 90.82% 95.31% 102.84% 27.71% 400.87% 182.89% 353.31% 213.88% 775.14% 248.58%
R&D to Revenue
314.17% 284.19% 307.06% 312.85% 85.66% 915.65% 350.66% 900.31% 520.49% 1,707.17% 586.14%
Operating Expenses to Revenue
412.40% 375.01% 402.37% 415.70% 113.36% 1,316.52% 533.55% 1,253.62% 734.38% 2,482.31% 834.73%
Earnings before Interest and Taxes (EBIT)
-40 -36 -39 -42 -2.03 -40 -31 -35 -37 -23 -23
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-42 -38 -40 -43 -2.53 -41 -29 -34 -36 -21 -21
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
5.00 2.83 2.91 3.81 1.46 1.29 1.97 5.19 5.56 22.85 0.00
Price to Tangible Book Value (P/TBV)
5.00 2.83 2.91 3.81 1.46 1.29 1.97 5.19 5.56 22.85 0.00
Price to Revenue (P/Rev)
6.92 5.25 7.92 7.37 1.84 1.38 1.73 4.34 8.09 12.88 16.10
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
1.26 0.00 0.00 0.00 0.00 0.00 0.00 0.26 0.00 2.20 4.34
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.07 0.10 0.13 0.17 0.32 0.94 -0.99
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.07 0.10 0.13 0.17 0.30 0.80 0.00
Financial Leverage
-3.62 -3.40 -3.27 -3.72 -3.65 -3.32 -3.61 -4.18 -4.13 -5.16 -7.53
Leverage Ratio
4.04 3.82 3.69 4.22 4.18 3.82 4.18 4.82 4.84 6.17 9.14
Compound Leverage Factor
4.04 3.82 3.69 4.22 4.18 3.82 4.18 4.82 4.84 6.17 9.14
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 6.89% 9.09% 11.82% 14.28% 24.02% 48.47% -8,072.13%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.91% 7.35% -8,072.13%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 6.89% 9.09% 11.82% 14.28% 23.11% 41.13% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 93.11% 90.91% 88.19% 85.72% 75.98% 51.53% 8,172.13%
Debt to EBITDA
0.00 0.00 0.00 0.00 -0.08 -0.07 -0.08 -0.09 -0.07 -0.08 -0.09
Net Debt to EBITDA
0.00 0.00 0.00 0.00 3.25 2.72 2.58 2.66 1.77 1.64 1.45
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 -0.08 -0.07 -0.08 -0.09 -0.07 -0.07 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 -0.09 -0.09 -0.10 -0.11 -0.09 -0.10 -0.11
Net Debt to NOPAT
0.00 0.00 0.00 0.00 3.98 3.38 3.16 3.25 2.26 2.06 1.84
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 -0.09 -0.09 -0.10 -0.11 -0.09 -0.09 0.00
Altman Z-Score
-0.08 -0.23 -0.64 -0.95 -1.18 -2.10 -2.51 -2.60 -3.79 -4.55 -5.84
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.18 3.53 3.52 3.29 3.40 3.34 3.78 3.76 3.83 5.25 5.26
Quick Ratio
3.08 3.41 3.41 3.21 3.31 3.23 3.64 3.64 3.68 5.04 5.05
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-117 -134 -113 -122 -143 -164 -150 -141 -89 -82 -71
Operating Cash Flow to CapEx
-19,772.53% -11,509.57% -18,634.12% -23,931.13% -31,808.09% -303,915.00% -490,460.00% -295,554.55% 0.00% -42,214.41% -110,377.42%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.14 0.14 0.09 0.10 0.18 0.17 0.18 0.16 0.06 0.06 0.05
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
4.10 4.21 2.50 2.98 5.16 4.77 4.79 4.46 1.50 1.41 1.21
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-415 -383 -353 -338 -277 -250 -227 -224 -216 -186 -173
Invested Capital Turnover
-0.21 -0.22 -0.14 -0.16 -0.29 -0.28 -0.28 -0.25 -0.09 -0.08 -0.07
Increase / (Decrease) in Invested Capital
84 103 81 88 137 133 126 114 62 64 54
Enterprise Value (EV)
123 -56 -66 -3.69 -219 -223 -158 18 -76 41 60
Market Capitalization
671 507 438 454 185 122 140 300 170 237 223
Book Value per Share
$1.59 $1.91 $1.56 $1.22 $1.29 $0.95 $0.71 $0.57 $0.28 $0.09 ($0.09)
Tangible Book Value per Share
$1.59 $1.91 $1.56 $1.22 $1.29 $0.95 $0.71 $0.57 $0.28 $0.09 ($0.09)
Total Capital
134 179 151 119 136 104 81 67 40 20 -0.12
Total Debt
0.00 0.00 0.00 0.00 9.39 9.46 9.54 9.61 9.69 9.77 9.85
Total Long-Term Debt
0.00 0.00 0.00 0.00 9.39 9.46 9.54 9.61 9.32 8.29 0.00
Net Debt
-549 -562 -503 -457 -404 -345 -298 -281 -246 -197 -163
Capital Expenditures (CapEx)
0.23 0.53 0.34 0.21 0.17 0.02 0.01 0.01 0.00 0.12 0.03
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-161 -146 -131 -130 -114 -98 -72 -71 -59 -31 -17
Debt-free Net Working Capital (DFNWC)
388 416 372 327 300 257 235 220 197 176 156
Net Working Capital (NWC)
388 416 372 327 300 257 235 220 197 174 146
Net Nonoperating Expense (NNE)
8.22 5.48 6.75 8.32 -3.00 9.18 6.63 8.34 9.57 5.49 5.91
Net Nonoperating Obligations (NNO)
-549 -562 -503 -457 -404 -345 -298 -281 -246 -197 -163
Total Depreciation and Amortization (D&A)
-2.55 -2.29 -1.68 -1.07 -0.50 -0.11 1.54 0.86 1.09 1.50 1.63
Debt-free, Cash-free Net Working Capital to Revenue
-165.88% -151.04% -237.57% -211.94% -113.01% -110.57% -89.31% -102.37% -278.97% -167.87% -123.34%
Debt-free Net Working Capital to Revenue
399.60% 432.00% 673.03% 531.38% 298.09% 290.79% 289.44% 319.23% 937.59% 953.46% 1,123.13%
Net Working Capital to Revenue
399.60% 432.00% 673.03% 531.38% 298.09% 290.79% 289.44% 319.23% 935.85% 945.43% 1,052.09%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.50) ($0.38) ($0.40) ($0.43) ($0.02) ($0.41) ($0.30) ($0.34) ($0.34) ($0.21) ($0.21)
Adjusted Weighted Average Basic Shares Outstanding
83.73M 93.81M 96.67M 97.52M 96.59M 99.40M 100.37M 102.60M 103.00M 110.59M 111.22M
Adjusted Diluted Earnings per Share
($0.50) ($0.38) ($0.40) ($0.43) ($0.02) ($0.41) ($0.30) ($0.34) ($0.34) ($0.21) ($0.21)
Adjusted Weighted Average Diluted Shares Outstanding
83.73M 93.81M 96.67M 97.52M 96.59M 99.40M 100.37M 102.60M 103.00M 110.59M 111.22M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
95.75M 96.38M 97.32M 97.93M 99.09M 99.99M 101.21M 109.15M 110.36M 111.03M 111.66M
Normalized Net Operating Profit after Tax (NOPAT)
-33 -31 -32 -34 -5.07 -31 -24 -26 -28 -17 -17
Normalized NOPAT Margin
-218.68% -192.51% -211.66% -220.99% -9.36% -851.57% -303.49% -807.53% -444.06% -1,667.62% -514.31%
Pre Tax Income Margin
-261.80% -226.97% -255.94% -275.19% -3.74% -1,101.55% -387.66% -1,063.40% -594.82% -2,192.16% -688.55%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Alector’s recent financial statements show a company with a substantially smaller operating cost base and improving cash-burn trends, but it remains deeply unprofitable and dependent on its liquidity and strategic funding sources. The latest quarter, Q2 2026, also highlights significant revenue volatility.

  • Operating expenses have declined meaningfully. Total operating expenses fell to $27.7 million in Q2 2026 from $42.0 million in Q2 2025 and $60.7 million in Q2 2024. Research and development expense declined to $19.5 million from $27.6 million and $46.3 million over the same comparison periods.
  • Quarterly operating cash burn has improved from 2024 levels. Cash used in operating activities was $34.2 million in Q2 2026, compared with $49.0 million in Q2 2025 and $62.8 million in Q2 2024. Q2 2026 was also an improvement from the $49.8 million burn recorded in Q1 2026.
  • Alector retains a meaningful liquidity cushion. Cash and short-term investments totaled approximately $172.0 million at June 30, 2026. Although this balance has declined substantially from more than $500 million in early 2024, it provides funding capacity relative to the latest quarterly operating cash burn.
  • Investment activity generated cash in recent quarters. Alector recorded $17.1 million of net cash from investing activities in Q2 2026, primarily because proceeds from investment maturities exceeded purchases. This helped partially offset the operating cash outflow, although it is not a recurring source of operating income.
  • Revenue remains highly inconsistent. Q2 2026 revenue was $3.3 million, up from $1.0 million in Q1 2026 but down from $7.9 million in Q2 2025 and $15.1 million in Q2 2024. The fluctuations suggest that revenue is not yet a dependable measure of the company’s underlying operating progress.
  • Deferred revenue remains a major balance-sheet item. Noncurrent deferred revenue was $162.9 million at June 30, 2026, roughly unchanged from Q1 2026 and Q2 2025. The balance may represent future revenue recognition, but the timing and conversion into reported revenue remain uncertain based on the data provided.
  • Other income continues to offset part of the operating loss. Net other income was $1.5 million in Q2 2026, compared with $2.0 million in Q1 2026 and $3.6 million in Q2 2025. This income appears helpful to results, but it does not replace the need for stronger operating revenue and profitability.
  • Several historical figures are identified as restated or calculated. Investors should use caution when comparing older quarters, particularly certain 2024 and 2025 income statement and cash-flow figures, because the supplied data includes restated and calculated periods.
  • Alector continues to report substantial net losses. The Q2 2026 net loss was $23.0 million, or $0.21 per diluted share. While this was better than the $30.5 million loss in Q2 2025 and the $38.7 million loss in Q2 2024, the company has remained loss-making throughout the periods provided.
  • The balance sheet moved into a deficit-equity position. Total liabilities of $212.8 million exceeded total assets of $202.9 million at June 30, 2026, producing negative shareholders’ equity of approximately $10.0 million. This compares with positive equity of $10.4 million in Q1 2026 and $57.7 million in Q3 2025.
  • Operating cash flow remains consistently negative. Alector has not generated positive operating cash flow in the reported quarters. Continued quarterly cash consumption could require additional financing, asset sales, licensing proceeds, or other strategic funding if operating performance does not improve.
  • Share dilution has increased over time. Weighted-average basic shares outstanding rose from approximately 93.8 million in Q1 2024 to 111.2 million in Q2 2026. Future equity financing could further dilute existing shareholders.

Overall, the trend is mixed. Alector has reduced expenses and narrowed its quarterly losses and cash burn, which extends the value of its remaining liquidity. However, revenue has declined from 2024 levels, operating losses persist, total liquidity has fallen sharply over the broader period, and the latest balance sheet shows negative equity. For investors, the key issues are whether Alector can convert its pipeline and deferred revenue into more consistent revenue while maintaining its lower expense structure without requiring substantial additional capital.

10/14/26 07:51 AM ETAI Generated. May Contain Errors.

Alector Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Alector's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Alector's net income appears to be on a downward trend, with a most recent value of -$142.93 million in 2025, falling from -$32.48 million in 2017. The previous period was -$119.05 million in 2024. Check out Alector's forecast to explore projected trends and price targets.

Alector's total operating income in 2025 was -$156.01 million, based on the following breakdown:
  • Total Gross Profit: $21.05 million
  • Total Operating Expenses: $177.05 million

Over the last 8 years, Alector's total revenue changed from $3.74 million in 2017 to $21.05 million in 2025, a change of 463.5%.

In the past 11 quarters, Alector's cash and equivalents has ranged from $37.16 million in Q3 2024 to $101.96 million in Q3 2023, and is currently $59.92 million as of their latest financial filing in Q2 2026.

Alector had total debt of $9.69 million at the end of 2025, a 3.2% increase from 2024, and none in 2017.

Over the last 8 years, Alector's book value per share changed from 0.00 in 2017 to 0.28 in 2025, a change of 28.1%.



Financial statements for NASDAQ:ALEC last updated on 8/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners